Security key
03753U106
Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (APLS)
CUSIP: 03753U106
Q4 2017 13F Holders as of 31 Dec 2017
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 127,672,507
- Total 13F shares
- 15,746,683
- Share change
- +15,746,683
- Total reported value
- $340,174,825
- Price per share
- $21.70
- Number of holders
- 46
- Value change
- +$340,174,825
- Number of buys
- 46
Report period
Q4 2017
Institutions
46
Top holders
10
APLS full security history
Newer quarter: Q1 2018
Apellis Pharmaceuticals, Inc. SEC filings
Apellis Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03753U106
Recent filing periods:
Top shareholders of APLS - Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (APLS) as of Q4 2017
As of 31 Dec 2017,
Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (APLS) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,746,683 shares.
The largest 10 holders included
Cormorant Asset Management, LLC, Sectoral Asset Management Inc, Vivo Capital, LLC, Hillhouse Capital Management, Ltd., EcoR1 Capital, LLC, BlackRock Inc., CLOUGH CAPITAL PARTNERS L P, RA CAPITAL MANAGEMENT, LLC, JENNISON ASSOCIATES LLC, and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C).
This page lists
46
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2017 vs Q4 2025 Across Filers
Q4 2025 holders
276
Q4 2017 holders
46
Holder diff
-230
| Investor | Q4 2025 Shares | Q4 2017 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q4 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.